Detection times and analytical performance of commercial urine opiate immunoassays following heroin administration

Michael L. Smith, Eric T. Shimomura, Jacquelyn Summers, Buddha D. Paul, Dan Nichols, Ronald Shippee, Amanda J. Jenkins, W. David Darwin, Edward J. Cone

Research output: Contribution to journalArticle

Abstract

The Federal Workplace Drug Testing Program changed urine screening and confirmation cutoff concentrations for opiate testing from 300 to 2000 ng/mL in 1998. Morphine was the designated target compound. An additional heroin metabolite, 6-acetylmorphine (6-AM), was added to the testing procedure with a cutoff concentration ≥ 10 ng/mL. Testing of 6-AM was required if morphine was positive to assist in medical review. A comparison of the new opiate cutoff concentrations was made with the older cutoff concentration at 300 ng/mL. Six commercial opiate immunoassays, four with a 300-ng/mL cutoff, ONLINE, EMIT, CEDIA and AxSym, and two with 2000-ng/mL cutoffs, ONLINE and EMIT, were selected to test 920 urine samples collected from 11 male human subjects following single doses of heroin. Eight received intravenous doses of 3, 6, and 12 mg heroin HCl and four smoked 3.5-, 5.2-, 10.5-, or 13.9-mg doses of heroin (base). In addition, 183 urine-based blind quality-control specimens were added to the study set to assess linearity, cross-reactivity, and interference. Total morphine, free morphine, and 6-AM were measured in each sample by gas chromatography-mass spectrometry (GC-MS). Linearity, cross-reactivity, and interference results for each immunoassay are described. Detection times, sensitivity, specificity, and efficiency of each assay were determined using data from the specimens collected after heroin administration. Detection times for morphine using the 300-ng/mL cutoff assays was approximately 12 h for low dose and 24 to 48 h for higher doses of heroin. For the two 2000-ng/mL cutoff concentration assays detection time was about 12 h. This was also the detection time for 6-AM by GC-MS. ONLINE had the lowest sensitivity, 60-74%, highest specificity, 98.8-100%, and least interference from a selection of common over-the-counter drugs and opioids. Increasing the cutoff to 2000 ng/mL from 300 ng/mL increased efficiencies of the assays from 72.7 to 82.6% to over 97%.

Original languageEnglish (US)
Pages (from-to)522-529
Number of pages8
JournalJournal of Analytical Toxicology
Volume24
Issue number7
StatePublished - 2000
Externally publishedYes

Fingerprint

Opiate Alkaloids
immunoassay
Heroin
Immunoassay
urine
Assays
Morphine
Urine
assay
Testing
Gas chromatography
Mass spectrometry
linearity
gas chromatography
drug
Gas Chromatography-Mass Spectrometry
mass spectrometry
Metabolites
Nonprescription Drugs
Quality control

ASJC Scopus subject areas

  • Analytical Chemistry
  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Smith, M. L., Shimomura, E. T., Summers, J., Paul, B. D., Nichols, D., Shippee, R., ... Cone, E. J. (2000). Detection times and analytical performance of commercial urine opiate immunoassays following heroin administration. Journal of Analytical Toxicology, 24(7), 522-529.

Detection times and analytical performance of commercial urine opiate immunoassays following heroin administration. / Smith, Michael L.; Shimomura, Eric T.; Summers, Jacquelyn; Paul, Buddha D.; Nichols, Dan; Shippee, Ronald; Jenkins, Amanda J.; Darwin, W. David; Cone, Edward J.

In: Journal of Analytical Toxicology, Vol. 24, No. 7, 2000, p. 522-529.

Research output: Contribution to journalArticle

Smith, ML, Shimomura, ET, Summers, J, Paul, BD, Nichols, D, Shippee, R, Jenkins, AJ, Darwin, WD & Cone, EJ 2000, 'Detection times and analytical performance of commercial urine opiate immunoassays following heroin administration', Journal of Analytical Toxicology, vol. 24, no. 7, pp. 522-529.
Smith, Michael L. ; Shimomura, Eric T. ; Summers, Jacquelyn ; Paul, Buddha D. ; Nichols, Dan ; Shippee, Ronald ; Jenkins, Amanda J. ; Darwin, W. David ; Cone, Edward J. / Detection times and analytical performance of commercial urine opiate immunoassays following heroin administration. In: Journal of Analytical Toxicology. 2000 ; Vol. 24, No. 7. pp. 522-529.
@article{83ad1030ded747359d36bb69c688abd3,
title = "Detection times and analytical performance of commercial urine opiate immunoassays following heroin administration",
abstract = "The Federal Workplace Drug Testing Program changed urine screening and confirmation cutoff concentrations for opiate testing from 300 to 2000 ng/mL in 1998. Morphine was the designated target compound. An additional heroin metabolite, 6-acetylmorphine (6-AM), was added to the testing procedure with a cutoff concentration ≥ 10 ng/mL. Testing of 6-AM was required if morphine was positive to assist in medical review. A comparison of the new opiate cutoff concentrations was made with the older cutoff concentration at 300 ng/mL. Six commercial opiate immunoassays, four with a 300-ng/mL cutoff, ONLINE, EMIT, CEDIA and AxSym, and two with 2000-ng/mL cutoffs, ONLINE and EMIT, were selected to test 920 urine samples collected from 11 male human subjects following single doses of heroin. Eight received intravenous doses of 3, 6, and 12 mg heroin HCl and four smoked 3.5-, 5.2-, 10.5-, or 13.9-mg doses of heroin (base). In addition, 183 urine-based blind quality-control specimens were added to the study set to assess linearity, cross-reactivity, and interference. Total morphine, free morphine, and 6-AM were measured in each sample by gas chromatography-mass spectrometry (GC-MS). Linearity, cross-reactivity, and interference results for each immunoassay are described. Detection times, sensitivity, specificity, and efficiency of each assay were determined using data from the specimens collected after heroin administration. Detection times for morphine using the 300-ng/mL cutoff assays was approximately 12 h for low dose and 24 to 48 h for higher doses of heroin. For the two 2000-ng/mL cutoff concentration assays detection time was about 12 h. This was also the detection time for 6-AM by GC-MS. ONLINE had the lowest sensitivity, 60-74{\%}, highest specificity, 98.8-100{\%}, and least interference from a selection of common over-the-counter drugs and opioids. Increasing the cutoff to 2000 ng/mL from 300 ng/mL increased efficiencies of the assays from 72.7 to 82.6{\%} to over 97{\%}.",
author = "Smith, {Michael L.} and Shimomura, {Eric T.} and Jacquelyn Summers and Paul, {Buddha D.} and Dan Nichols and Ronald Shippee and Jenkins, {Amanda J.} and Darwin, {W. David} and Cone, {Edward J.}",
year = "2000",
language = "English (US)",
volume = "24",
pages = "522--529",
journal = "Journal of Analytical Toxicology",
issn = "0146-4760",
publisher = "Preston Publications",
number = "7",

}

TY - JOUR

T1 - Detection times and analytical performance of commercial urine opiate immunoassays following heroin administration

AU - Smith, Michael L.

AU - Shimomura, Eric T.

AU - Summers, Jacquelyn

AU - Paul, Buddha D.

AU - Nichols, Dan

AU - Shippee, Ronald

AU - Jenkins, Amanda J.

AU - Darwin, W. David

AU - Cone, Edward J.

PY - 2000

Y1 - 2000

N2 - The Federal Workplace Drug Testing Program changed urine screening and confirmation cutoff concentrations for opiate testing from 300 to 2000 ng/mL in 1998. Morphine was the designated target compound. An additional heroin metabolite, 6-acetylmorphine (6-AM), was added to the testing procedure with a cutoff concentration ≥ 10 ng/mL. Testing of 6-AM was required if morphine was positive to assist in medical review. A comparison of the new opiate cutoff concentrations was made with the older cutoff concentration at 300 ng/mL. Six commercial opiate immunoassays, four with a 300-ng/mL cutoff, ONLINE, EMIT, CEDIA and AxSym, and two with 2000-ng/mL cutoffs, ONLINE and EMIT, were selected to test 920 urine samples collected from 11 male human subjects following single doses of heroin. Eight received intravenous doses of 3, 6, and 12 mg heroin HCl and four smoked 3.5-, 5.2-, 10.5-, or 13.9-mg doses of heroin (base). In addition, 183 urine-based blind quality-control specimens were added to the study set to assess linearity, cross-reactivity, and interference. Total morphine, free morphine, and 6-AM were measured in each sample by gas chromatography-mass spectrometry (GC-MS). Linearity, cross-reactivity, and interference results for each immunoassay are described. Detection times, sensitivity, specificity, and efficiency of each assay were determined using data from the specimens collected after heroin administration. Detection times for morphine using the 300-ng/mL cutoff assays was approximately 12 h for low dose and 24 to 48 h for higher doses of heroin. For the two 2000-ng/mL cutoff concentration assays detection time was about 12 h. This was also the detection time for 6-AM by GC-MS. ONLINE had the lowest sensitivity, 60-74%, highest specificity, 98.8-100%, and least interference from a selection of common over-the-counter drugs and opioids. Increasing the cutoff to 2000 ng/mL from 300 ng/mL increased efficiencies of the assays from 72.7 to 82.6% to over 97%.

AB - The Federal Workplace Drug Testing Program changed urine screening and confirmation cutoff concentrations for opiate testing from 300 to 2000 ng/mL in 1998. Morphine was the designated target compound. An additional heroin metabolite, 6-acetylmorphine (6-AM), was added to the testing procedure with a cutoff concentration ≥ 10 ng/mL. Testing of 6-AM was required if morphine was positive to assist in medical review. A comparison of the new opiate cutoff concentrations was made with the older cutoff concentration at 300 ng/mL. Six commercial opiate immunoassays, four with a 300-ng/mL cutoff, ONLINE, EMIT, CEDIA and AxSym, and two with 2000-ng/mL cutoffs, ONLINE and EMIT, were selected to test 920 urine samples collected from 11 male human subjects following single doses of heroin. Eight received intravenous doses of 3, 6, and 12 mg heroin HCl and four smoked 3.5-, 5.2-, 10.5-, or 13.9-mg doses of heroin (base). In addition, 183 urine-based blind quality-control specimens were added to the study set to assess linearity, cross-reactivity, and interference. Total morphine, free morphine, and 6-AM were measured in each sample by gas chromatography-mass spectrometry (GC-MS). Linearity, cross-reactivity, and interference results for each immunoassay are described. Detection times, sensitivity, specificity, and efficiency of each assay were determined using data from the specimens collected after heroin administration. Detection times for morphine using the 300-ng/mL cutoff assays was approximately 12 h for low dose and 24 to 48 h for higher doses of heroin. For the two 2000-ng/mL cutoff concentration assays detection time was about 12 h. This was also the detection time for 6-AM by GC-MS. ONLINE had the lowest sensitivity, 60-74%, highest specificity, 98.8-100%, and least interference from a selection of common over-the-counter drugs and opioids. Increasing the cutoff to 2000 ng/mL from 300 ng/mL increased efficiencies of the assays from 72.7 to 82.6% to over 97%.

UR - http://www.scopus.com/inward/record.url?scp=0033814376&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033814376&partnerID=8YFLogxK

M3 - Article

C2 - 11043654

AN - SCOPUS:0033814376

VL - 24

SP - 522

EP - 529

JO - Journal of Analytical Toxicology

JF - Journal of Analytical Toxicology

SN - 0146-4760

IS - 7

ER -